Volume 14, Number 4—April 2008
Rat-to-Elephant-to-Human Transmission of Cowpox Virus
Highlight and copy the desired format.
|EID||Kurth A, Wibbelt G, Gerber H, Petschaelis A, Pauli G, Nitsche A, et al. Rat-to-Elephant-to-Human Transmission of Cowpox Virus. Emerg Infect Dis. 2008;14(4):670-671. https://dx.doi.org/10.3201/eid1404.070817|
|AMA||Kurth A, Wibbelt G, Gerber H, et al. Rat-to-Elephant-to-Human Transmission of Cowpox Virus. Emerging Infectious Diseases. 2008;14(4):670-671. doi:10.3201/eid1404.070817.|
|APA||Kurth, A., Wibbelt, G., Gerber, H., Petschaelis, A., Pauli, G., & Nitsche, A. (2008). Rat-to-Elephant-to-Human Transmission of Cowpox Virus. Emerging Infectious Diseases, 14(4), 670-671. https://dx.doi.org/10.3201/eid1404.070817.|
To the Editor: Despite the eradication of smallpox in the past century, other orthopoxviruses, such as monkeypox virus, vaccinia virus in Brazil, and cowpox virus (CPXV) in Europe (1), still infect humans. CPXV has been restricted to the Old World with wild rodents as its natural reservoir (2,3). Human CPXV infections are commonly described in relation to contact with diseased domestic cats, rarely directly from rats (2,4). Human infections usually remain localized and self-limiting but can become fatal in immunosuppressed patients (5). CPXV infections in captive exotic animals have been reported to be transmitted by rodents (2,6).
In February 2007, a circus elephant (Elephas maximus) in northern Germany exhibited disseminated ulcerative lesions of the skin and mucosal membranes (Figure, panel A) caused by CPXV infection; the elephant was euthanized after treatment attempts failed. Electron micrographs of negative-stained biopsy specimens of tongue lesions showed orthopoxvirus particles. The presence of orthopoxvirus after routine virus isolation in Hep2 cells was confirmed in direct immunofluorescence assay with orthopox-specific antibodies. The morphologic feature of hemorrhagic pocks on the chorioallantoic membrane (CAM) of infected embryonated hen’s eggs indicated CPXV. This finding was confirmed by sequence analysis of the complete hemagglutinin (HA) open reading frame (ORF), which showed 99% homology of 921 bp to CPXV isolated in 1984 from an elephant in Hamburg, Germany (Figure, panel B). A serum sample was drawn from the elephant 2 weeks before euthanasia. An indirect fluorescent antibody test (IFAT) detected immunoglobulin (Ig) G antibodies against the new corresponding elephant virus isolate (termed CPXV GuWi) with a titer of 1,260. According to the owner, the >40-year-old female elephant had never been vaccinated with vaccinia virus.
Eight days after the elephant’s death, a circumscribed lesion developed on the back of the right hand of a 19-year-old immunocompetent, healthy, unvaccinated animal keeper. CPXV was isolated from lesion fluid and was found to be homologous by using the HA ORF to CPXV GuWi. A convalescent-phase serum sample from the keeper taken 3 weeks later showed a significant increase in IgM (from 40 to 2,560), IgG (from 20 to 10,240), and neutralizing antibody (from <5 to 80) titers.
Further simultaneous investigations were undertaken to determine the source of infection. Because no felids were kept on the circus premises, the focus centered on wild rodents that had propagated and infested the area because of the mild winter. Six days after the elephant’s death, 4 rats (Rattus norvegicus) were caught and tested for orthopoxvirus antibodies. Although none of the rats had epidermal lesions or other pathologic changes indicative of a poxvirus infection, all were tested by IFAT and found to be serologically positive (IgG titers 40, 320, 2,560, and >10,240; IgM titers <5, <5, 160, and 2,560), indicating a recent infection in at least 2 animals. CPXV-typical pock morphologic features on the CAM could be visualized after homogenized liver and spleen of the animal with the highest titer was passaged 3 times. Infected CAM and original organ tissues (liver and spleen) showed CPXV by PCR and subsequent sequencing. The corresponding HA ORF displayed perfect homology to the viruses isolated from the elephant and the animal keeper.
We report CPXV infection in humans transmitted from an elephant, with rats as a probable source of the elephant’s infection (Figure, panel A). Although the animal keeper was infected by direct contact with the elephant, the exact transmission route from rat to elephant remains unclear. Nevertheless, rats have proven to be a natural reservoir for CPXV (4,7), and infections persisting for >3 weeks were shown for other rodents (8). No data about CPXV prevalence in rats are available, and no data for CPXV isolates from rats have been published in Germany. Therefore, further studies on rats as CPXV reservoir are needed to estimate the potential risk for infection among humans and exotic animals. Zoo and circus animals, especially elephants, seem to be highly susceptible to generalized CPXV infections. Although modified vaccinia virus Ankara was authorized in Germany to be used in vaccinating exotic animals (9), this case highlights the need for increased efforts toward general vaccination of potentially susceptible exotic animals in Europe.
The sequence identity of the HA ORFs also demonstrates a low mutation rate of CPXV after it crosses species barriers. As the Figure, panel B, infers, there is a phylogenetic difference between CPCV GuWi and CPXV from a human patient living in the same geographic area (CPXV #2), which indicates the cocirculation of >1 CPXV variant (9,10). Considering the extremely high virus load in infected animals, the broad host range of CPXV, and the abandoned vaccination against smallpox, this case emphasizes the risk among humans of acquiring CPXV infection (6). It also highlights the need for increased awareness regarding clinical features of orthopoxvirus infections and the importance of developing new antiviral drugs against orthopoxviruses.
We are grateful to Delia Barz, Jung-Won Sim-Brandenburg, and Julia Tesch for excellent technical assistance and Allen Curry and Ursula Erikli for their dedicated editorial help.
- Kurth A, Nitsche A. Fast and reliable diagnostic methods for the detection of human poxvirus infections. Future Virology. 2007;2:467–79.
- Baxby D, Bennett M, Getty B. Human cowpox 1969–93: a review based on 54 cases. Br J Dermatol. 1994;131:598–607.
- Chantrey J, Meyer H, Baxby D, Begon M, Bown KJ, Hazel SM, Cowpox: reservoir hosts and geographic range. Epidemiol Infect. 1999;122:455–60.
- Wolfs TF, Wagenaar JA, Niesters HG, Osterhaus AD. Rat-to-human transmission of cowpox infection. Emerg Infect Dis. 2002;8:1495–6.
- Eis-Hubinger AM, Gerritzen A, Schneweis KE, Pfeiff B, Pullmann H, Mayr A, Fatal cowpox-like virus infection transmitted by cat. Lancet. 1990;336:880.
- Baxby D, Bennett M. Cowpox: a re-evaluation of the risks of human cowpox based on new epidemiological information. Arch Virol Suppl. 1997;13:1–12.
- Martina BE, van Dornum DG, Dorrstein GM, Niesters HG, Stittelaar KJ, Wolters MA, Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis. 2006;12:1005–7.
- Marennikova SS, Ladnyj ID, Ogorodinikova ZI, Shelukhina EM, Maltseva NN. Identification and study of a poxvirus isolated from wild rodents in Turkmenia. Arch Virol. 1978;56:7–14.
- Essbauer S, Meyer H. Genus orthopoxvirus: cowpox virus. In: Mercer AA, Schmidt A, Weber O, editors. Poxviruses. Basel (Switzerland): Birkhäuser, 2007. p.75–88.
- Begon S, Hazel SM, Baxby D, Bown K, Cavanagh R, Chantrey J, Transmission dynamics of a zoonotic pathogen within and between wildlife host species. Proc Biol Sci. 1999;266:1939–45.
- Figure. Route of cowpox virus (CPXV) transmission and phylogenetic analysis of orthopoxviruses. A) Disseminated ulcerative lesions of the skin around the eye of the circus elephant. Although transmission of CPXV has...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Andreas Kurth, Center for Biological Safety 1, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 13, 2010
- Page last updated: July 13, 2010
- Page last reviewed: July 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)